logo
episode-header-image
May 2023
28m 43s

Ozempic the Anti-Addiction Drug, Age of ...

Morning Brew
About this episode
Episode 65: Neal and Toby discuss the increasing buzz around potent weight loss drugs with Pfizer's oral version and Ozempic's anti-addiction side effects. Then, Showtime merges with Paramount+, Max absorbs Discovery+, and Disney+ wants to include Hulu. Are we entering the age of streaming mergers? Meanwhile, Western states reach a deal that might stop its m ... Show More
Up next
Yesterday
American AI Companies Fend Off Chinese Copy Cats & Gen Z Loves Love Island
#884: American AI companies are sounding the alarm on Chinese companies copying their models through “distillation.” Stellantis officially opens its doors to the sale of the tiny car priced at under $15,000. The US is seeing its middle-aged population slowly shrinking and which c ... Show More
29m 31s
Jul 7
Xbox Hits Reset Button on Business & Netflix Has a ‘Season 2’ Problem
#883: Microsoft cuts over 4,000 jobs including its Xbox unit as it looks to downsize its gaming division. SpaceX joins the Nasdaq in less than a month of it becoming public. Netflix has a retention problem as it struggles to keep viewers hooked onto its shows after its first seas ... Show More
30m 1s
Jul 6
Trump Accounts Are Now Live & Philosophy Majors Find Work in AI
#882: What you need to know about the Trump accounts that are now live. Scientists have made a cell from scratch for the first time. Bending Spoons raises $1 billion in its IPO. AI labs are turning to philosophy majors to help solve some of the tech’s most complex problems. Final ... Show More
31m 29s
Recommended Episodes
Oct 2023
Ozempic’s Success Is Bad News for Rivals
Bloomberg News Health Reporter Madison Muller discusses how the drug Ozempic could cut demand for big-money drugs targeting a wide range of maladies, even Alzheimer’s. Hosts: Carol Massar and Tim Stenovec. Producer: Paul Brennan.See omnystudio.com/listener for privacy information ... Show More
7m 10s
Jul 2023
One Thing: Weight Loss Drugs: Trend or Treatment?
A new group of drugs for type 2 diabetes and obesity have shown to be more effective for weight loss than any previous medications. Some medications like Ozempic and Wegovy have surged in popularity thanks in part to celebrity use. But who should be taking them? And are they safe ... Show More
17m 14s
Nov 2025
Pfizer plays hardball in weight-loss drug fight
Palantir lifted its 2025 revenue guidance and Pfizer has filed a second lawsuit against Novo Nordisk and obesity drug start-up Metsera. Plus, OpenAI inked a $38bn computing deal with Amazon, and the FT’s Claire Jones explains how the Trump administration is considering pushing fo ... Show More
11m 3s
Apr 2023
🏋️ “A slimdown in a syringe” — Weight Watchers’ Ozempic win. Rihanna’s perfume power. Tax Day’s big battle.
The latest fad diet isn’t a diet, it’s a shot — Ozempic is being called a miracle weight loss drug, and it’s disrupting Weight Watchers. LVMH is proud of their pricey perfume, and they are selling more than ever thanks to their Rihanna-aided storytelling. And H&R Block vs. TurboT ... Show More
22m 14s
Oct 2025
Big Pharma Breakout… And A Billionaire Boycott On Netflix 10/1/25
<p>Pharma stocks breaking out, as President Trump inks a drug pricing deal. What it means for the group, and how the broader health care sector is breathing a sigh of relief. Plus Elon Musk and some bingeing backlash. Why the billionaire is calling for customers to cancel their s ... Show More
41m 11s
Listen to millions of songs and podcasts on Anghami